Pharmaceutical

Genentech secures FDA approval for Lunsumio VELO SC for...

The approval is based on the Phase I/II GO29781 clinical study, with full approv...

Samsung Biologics to acquire Human Genome Sciences

The move will give Samsung Biologics its first manufacturing site in the country...

Union Minister highlights role of Arya Vaidya Sala in S...

ASK@62 seminar held in New Delhi for the first time as Arya Vaidya Sala marks ...

FDA approves Novo Nordisk’s oral Wegovy pill for weight...

Approval covers once-daily oral semaglutide 25 mg based on OASIS and SELECT tri...

Biocon Biologics secures global manufacturing and comme...

Agreement with Fujifilm Kyowa Kirin Biologics covers biosimilar Adalimumab The ...

Glenmark launches Epinephrine Injection USP multiple-do...

Product introduced for institutional channel in the US market The post Glenmar...

MEDIPOST, Teikoku Seiyaku partner for CARTISTEM commerc...

The agreement covers the promotion license, sales, and distribution of CARTISTEM...

Cytokinetics receives FDA approval for MYQORZO tablets ...

In patients suffering with oHCM, myosin inhibition with MYQORZO, which is an all...

Novartis, US government reach agreement to lower drug p...

Under the agreement, Novartis has voluntarily committed to several actions. Thes...

Emcure launches Poviztra semaglutide injection in India

Company begins commercial distribution of Novo Nordisk product for weight manag...

Piramal Consumer Healthcare unveils Lacto Calamine iden...

Brand marks six decades of skincare use and portfolio expansion The post Pirama...

Granules Pharma receives USFDA tentative approval for a...

Approval covers multiple strengths for ADHD treatment, to be manufactured at US...

MHRA launches call for evidence on AI regulation in UK ...

The initiative aims to shape future standards and safeguards for the way AI is u...

J&J receives FDA approval for lung cancer therapy

The approval covers all existing indications for Rybrevant. The SC formulation r...

Pfizer India partners with Cipla for marketing and dist...

Cipla to market and distribute five Pfizer medicines in India under new agreeme...

EC approves Incyte’s Minjuvi combo for follicular lymphoma

FL is the most common slow-growing B-cell non-Hodgkin lymphoma form. Minjuvi is ...